Risk owners comprising the first line of defense have come to count on compliance as a crucial support function. Perhaps too much, in some cases. “Early in my career, when I would talk to internal ...
Semaglutide or tirzepatide should be first-line drugs for obesity and most of its related complications, new guidance from the European Association for the Study of Obesity recommended. The authors of ...
David Hung, Founder, President, CEO & Chairman, highlighted that "2025 was a pivotal year for Nuvation Bio" due to the full U.S. FDA approval of IBTROZI for advanced ROS1-positive non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results